Thursday 20 August 2026

One To Watch

AVVA Pharmaceuticals

Company Overview

Want to Update your Company's Profile?


Latest AVVA Pharmaceuticals News

AstraZeneca to invest $1.2 billion in Russia by 2017; Pharmstandard deal with AVVA
28 December 2012
More AVVA Pharmaceuticals news >


Today's issue

Opdivo intravenous infusion wins additional approval in Taiwan
Biotechnology
Opdivo intravenous infusion wins additional approval in Taiwan
19 August 2026
Pharmaceutical
FDA accepts Teva's NDA for ecopipam, grants priority review for pediatric Tourette syndrome
19 August 2026
Biotechnology
Kynexis raises 97 million euros to advance med for cognitive disorders
19 August 2026
Biotechnology
Merck and Moderna announce Phase III INTerpath-001 trial of intismeran combo
19 August 2026
Pharmaceutical
Latin America assesses and analyzes how to overcome immunization barriers in the region
19 August 2026
Pharmaceutical
Lundbeck reports financials with strong growth from Vyepti
19 August 2026
Biotechnology
Piramal completes buy of controlling stake in Yapan Bio, expanding biologics CDMO capabilities
19 August 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze